Abstract | BACKGROUND: METHODS: Consecutive patients admitted in 2013 and 2015 were enrolled in the present study. The logistic regression analysis was conducted to evaluate predictors of 3-month outcomes. The primary endpoint was death. Secondary endpoint was good (modified Rankin Scale score 0-2 or equal to prestrike modified Rankin Scale score) at 3 months. RESULTS: Of 871 patients enrolled in the final analysis, 94 (10.8%) individuals died during 3 months of observation. The serum TC and TC/HDL-C levels at admission were significantly associated with stroke outcomes at 3 months, and the HDL-C level was only correlated with the good outcomes at 3 months. Mortality risk was markedly decreased for patients with high TC/HDL-C ratio (odds ratio: 0.23, 95% confidence interval [CI]: 0.10-0.50 for Q4:Q1; P-trend <.001) after adjustment. The effect of TC/HDL-C ratio on the probability of good outcomes was still obvious (odds ratio: 2.18, 95% CI: 1.40-3.39 for Q4:Q1; P-trend=.029). According to the receiver operating characteristic analyses, the best discriminating factor was a TG/HDL-C ≥3.37 (area under the ROC curve [AUC]=0.643, sensitivity 61.3%, specificity 61.7%) as well as the TC/HDL-C ≥4.09 for good outcomes (AUC: 0.587, sensitivity 63.9%, specificity 79.7%). CONCLUSIONS: High TC/HDL-C ratio may be associated with increased short-term survival and better outcomes after AIS.
|
Authors | Lifang Chen, Jianing Xu, Hao Sun, Hao Wu, Jinsong Zhang |
Journal | Journal of clinical laboratory analysis
(J Clin Lab Anal)
Vol. 31
Issue 6
(Nov 2017)
ISSN: 1098-2825 [Electronic] United States |
PMID | 28124804
(Publication Type: Journal Article)
|
Copyright | © 2017 Wiley Periodicals, Inc. |
Chemical References |
- Cholesterol, HDL
- Cholesterol
|
Topics |
- Aged
- Aged, 80 and over
- China
(epidemiology)
- Cholesterol
(blood)
- Cholesterol, HDL
(blood)
- Female
- Humans
- Male
- Middle Aged
- Predictive Value of Tests
- Prognosis
- ROC Curve
- Stroke
(blood, epidemiology, mortality)
- Treatment Outcome
|